Aveanna Healthcare Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Aveanna Healthcare Holdings, Inc. (AVAH) on February 17, 2026. The filing discloses the execution of new employment agreements with three Named Executive Officers (NEOs) effective February 17, 2026: Jeff Shaner (President and CEO), Matthew Buckhalter (CFO), and Jerry Perchik (Chief Legal Officer and Secretary).
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on executive compensation arrangements.
Material Changes and Compensation Details
The new agreements replace prior employment contracts and establish the following compensation structures:
- Base Salaries: $750,000 for Mr. Shaner; $500,000 for Mr. Buckhalter; $450,000 for Mr. Perchik.
- Target Annual Bonuses: 100% of base salary for Mr. Shaner; 75% of base salary for Mr. Buckhalter and Mr. Perchik.
- Equity: Eligibility for discretionary annual grants under the 2021 Stock Incentive Plan.
Severance and Change in Control Provisions
The agreements outline specific severance benefits triggered by termination without "Cause" or resignation for "Good Reason":
- Outside Change in Control Period:
- Mr. Shaner: 2x multiple of (Base Salary + Target Bonus) plus pro-rated bonus, pro-rated equity vesting, and 24 months of subsidized COBRA.
- Other NEOs: 1x multiple of (Base Salary + Target Bonus) plus pro-rated bonus, pro-rated equity vesting, and 12 months of subsidized COBRA.
- During Change in Control Period:
- Mr. Shaner: 2.5x multiple of (Base Salary + Target Bonus) plus pro-rated bonus, full equity vesting, and 30 months of subsidized COBRA.
- Other NEOs: 2x multiple of (Base Salary + Target Bonus) plus pro-rated bonus, full equity vesting, and 24 months of subsidized COBRA.
Receipt of these benefits is contingent upon the timely execution of a release of claims.
Investor Verification Checklist
- Review the full text of Exhibits 99.1, 99.2, and 99.3 for specific definitions of "Cause," "Good Reason," and "Change in Control Period."
- Verify the total potential cash and equity payout obligations under the new agreements compared to the prior contracts.
- Assess the impact of the increased base salaries and bonus targets on the company's future operating expenses.
- Confirm the status of the 2021 Stock Incentive Plan to ensure sufficient shares remain available for the discretionary grants mentioned.